Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsGynecologic OncologyDecember 2025Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)Shahin M, Mathur R, Parthan A, et al.Real-world evidencePublication summaryPublicationsComparative effectivenessOvarian cancerBlood Cancer JournalDecember 2025Utilization of real-world evidence in regulatory approvals for multiple myeloma therapiesTaylor L, Chen A, Pierre A. Publication summaryPublicationsMultiple myelomaRegulatorySABCSDecember 2025Real-world glucagon-like peptide-1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancerRyals C, Blarre A, Adamson B, et al.Publication summaryPublicationsBreast cancer